Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FENXS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,589
Award facts
- Contract value 100% obligated
- $10,588.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,588.89 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This firm fixed-price delivery order, issued on December 15, 2025, with an ultimate completion date of December 18, 2025, represents a single purchase under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with DLA. The delivery order carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group has been registered in the System for Award Management since 2001 and serves as a critical supplier within the federal pharmaceutical supply chain, specializing in distributing branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables to Department of Defense healthcare facilities.
This delivery order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion DLA acquisition strategy designed to support recurring medical supply needs of military healthcare facilities worldwide. DMS Pharmaceutical Group's prime vendor contract under this program, designated SPE2DR and awarded on November 13, 2025, carries a ceiling value of $499,999,999 with a completion date of December 31, 2036, structured as a 30-month base period with three 30-month option periods. The company's extensive product portfolio and demonstrated performance on numerous prior delivery orders position it as a key regional pharmaceutical supplier capable of fulfilling the diverse and specialized pharmaceutical requirements of Department of Defense military medical operations globally.
Quick answers
Who was awarded contract SPE2DU26FENXS?
SPE2DU26FENXS was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DU26FENXS worth?
The government has obligated $10,589 on SPE2DU26FENXS.
Is contract SPE2DU26FENXS an order under another contract?
Yes. SPE2DU26FENXS is a delivery order under SPE2DU25D9418, an indefinite delivery contract.
Was contract SPE2DU26FENXS competed?
The extent of competition for SPE2DU26FENXS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award